Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    22010913 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  TB-IRIS NSAID Cox-2 Inhibitor Prevention Trial
Condition: Tuberculosis
Intervention: Drug: Meloxicam 7.5mg daily for 8 weeks
2 Completed Early vs Late Introduction of Antiretroviral Therapy in HIV-infected Patients With Tuberculosis (ANRS 1295 CAMELIA)
Conditions: HIV Infection;   Tuberculosis
Interventions: Procedure: Early antiretroviral treatment;   Procedure: Late antiretroviral treatment

Indicates status has not been verified in more than two years